我国政府医药科技投入对企业研发支出影响的实证分析  

Empirical Analysis on the Effect of Pharmaceutical Scientific & Technological Investment from Government on Pharmaceutical R&D Expenditure

作　　者：孙燕[1] 孙利华[1] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳市110016

出　　处：《中国药房》2011年第9期771-774,共4页China Pharmacy

摘　　要：目的:为提高我国政府医药科技投入的使用效率,促进企业增加研发投入,提高创新能力提供参考性政策建议。方法:构建多元线性回归模型,分析近年来我国政府医药科技投入对企业研发支出的影响,并进行相关性分析。结果与结论:在样本期内政府医药科技投入对企业研发支出具有挤出效应,挤出效应最终反映在企业委托科研机构研发经费支出上;政府向医药科研机构拨款对医药企业研发支出影响不显著。建议通过调整医药科研机构研发投入结构,提高医药科研机构知识产权保护意识,调动"供体"活力、激发"受体"动力、完善"媒体"建设等措施,消除政府投入的挤出效应,发挥杠杆效应。OBJECTIVE： To provide reference for promoting the utilization ratio of pharmaceutical scientific ＆ technological investment from government, R＆D expenditure and innovation ability. METHODS： The multiple linear regression model was established to analyze the effect of pharmaceutical scientific ＆ technological investment from government on R＆D expenditure. And a correlation analysis was conducted. RESULTS ＆ CONCLUSIONS： During the sample period, government investments crowd out the enterprise expenditures which are ultimately reflected by the expenditures of enterprise for R＆D authorizing research institu- tions. However, government investment to research institutions doesn＇t significantly affect the R＆D expenditures of pharmaceutical companies. It is suggested to adjust the R＆D investment structure of medical research institutions and improve the awareness of intellectual property protection, mobilize the vitality of ＂donor＂ and ＂receptor＂, improve ＂media＂ construction and eliminate the ＂crowding-out effect＂ and give full play to ＂leverage effect＂.

关 键 词：政府:医药科技投入 企业 研发支出 挤出效应 杠杆效应 实证分析 

分 类 号：F273[经济管理—企业管理] F763[经济管理—国民经济]